166
Participants
Start Date
August 20, 2025
Primary Completion Date
December 1, 2030
Study Completion Date
July 1, 2031
Reduced-Target Radiotherapy
Experimental group: GTVnx: 69.96 Gy/33 Fr/2.12 Gy; GTVnd: 69.96 Gy/33 Fr/2.12 Gy; CTV1: 60.60 Gy/33 Fr/1.82 Gy; GTV2: No prescription dose (only delineated, actual dose is scattered dose).
Conventional Full-Target Radiotherapy
Control group: GTVnx: 69.96 Gy/33 F/2.12 Gy; GTVnd: 69.96 Gy/33 F/2.12 Gy; CTV1: 59.4 Gy/33 F/1.8 Gy; CTV2: 54 Gy/33 F/1.64 Gy.
RECRUITING
The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000 Recruiting, Zhuhai
Fifth Affiliated Hospital, Sun Yat-Sen University
OTHER
Sun Yat-sen University
OTHER
Cancer Hospital of Guangxi Medical University
OTHER
Fujian Cancer Hospital
OTHER_GOV
The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University
UNKNOWN
Sun Yat-sen University Cancer Center, Sun Yat-sen University
UNKNOWN
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
OTHER
Zhejiang Cancer Hospital
OTHER
West China Hospital
OTHER
Xiangya Hospital of Central South University
OTHER
Affiliated Cancer Hospital of Shantou University Medical College
OTHER
Yunnan Cancer Hospital
OTHER
First Affiliated Hospital of Kunming Medical University
OTHER
Wuzhou Red Cross Hospital
OTHER
Zhongshan People's Hospital, Guangdong, China
OTHER
Southern Medical University, China
OTHER
Ming-Yuan Chen
OTHER